CellFX nsPFA Cardiac Surgery System to Treat Atrial Fibrillation (NANOCLAMP AF STUDY) - Clinical Trial
What is the Purpose of this Study?
In this study, you will have a heart procedure called an ablation using a special system called the nsPFA Cardiac Surgery System. After the procedure, you will have follow up visits at one month, three months, six months, and twelve months. Around each visit, you will wear a heart monitor to track your heart rhythm and use a phone app to share information. The study team will also collect information about your medicines and your health during the study.
Atrial fibrillation
Who Can Participate in the Study?
People can join this study if they have had atrial fibrillation and are scheduled to have planned heart surgery that is not an emergency. They cannot join if they have a pacemaker, an artificial heart valve, kidney failure, or a long term lung disease called chronic obstructive pulmonary disease.
What is Involved?
The purpose of this study is to find out if a medical system called the CellFX nsPFA Cardiac Surgery System is safe and works well to treat a heart rhythm problem called atrial fibrillation. Researchers want to learn how well this system helps fix the irregular heartbeat and keeps patients safe during and after treatment.
Study Details
